152 related articles for article (PubMed ID: 18337664)
1. Clinical usefulness of FDG-PET/CT scan imaging in the management of posttransplant lymphoproliferative disease.
Bianchi E; Pascual M; Nicod M; Delaloye AB; Duchosal MA
Transplantation; 2008 Mar; 85(5):707-12. PubMed ID: 18337664
[TBL] [Abstract][Full Text] [Related]
2. The value of 18F-FDG PET in pediatric patients with post-transplant lymphoproliferative disorder at initial diagnosis.
Vali R; Punnett A; Bajno L; Moineddin R; Shammas A
Pediatr Transplant; 2015 Dec; 19(8):932-9. PubMed ID: 26515450
[TBL] [Abstract][Full Text] [Related]
3. (18)F-FDG PET/CT in the management of patients with post-transplant lymphoproliferative disorder.
Takehana CS; Twist CJ; Mosci C; Quon A; Mittra E; Iagaru A
Nucl Med Commun; 2014 Mar; 35(3):276-81. PubMed ID: 24296883
[TBL] [Abstract][Full Text] [Related]
4. End-of-Treatment Positron Emission Tomography After Uniform First-Line Therapy of B-Cell Posttransplant Lymphoproliferative Disorder Identifies Patients at Low Risk of Relapse in the Prospective German PTLD Registry.
Zimmermann H; Denecke T; Dreyling MH; Franzius C; Reinke P; Subklewe M; Amthauer H; Kneba M; Riess H; Trappe RU
Transplantation; 2018 May; 102(5):868-875. PubMed ID: 29189632
[TBL] [Abstract][Full Text] [Related]
5. Post transplant lymphoproliferative disease in pediatric solid organ transplant patients: a possible role for [18F]-FDG-PET(/CT) in initial staging and therapy monitoring.
von Falck C; Maecker B; Schirg E; Boerner AR; Knapp WH; Klein C; Galanski M
Eur J Radiol; 2007 Sep; 63(3):427-35. PubMed ID: 17293073
[TBL] [Abstract][Full Text] [Related]
6.
Montes de Jesus FM; Glaudemans AWJM; Tissing WJ; Dierckx RAJO; Rosati S; Diepstra A; Noordzij W; Kwee TC
J Nucl Med; 2020 Sep; 61(9):1307-1313. PubMed ID: 32005775
[TBL] [Abstract][Full Text] [Related]
7. FDG-PET/CT in abdominal post-transplant lymphoproliferative disease.
Metser U; Lo G
Br J Radiol; 2016; 89(1057):20150844. PubMed ID: 26544161
[TBL] [Abstract][Full Text] [Related]
8. Both native and ectopically transplanted hearts shown on FDG PET/CT in a PTLD patient.
Sonoda LI; Sanghera B; Gogbashian A; Lambert J; Wong WL
Clin Nucl Med; 2012 Oct; 37(10):1022-3. PubMed ID: 22899204
[TBL] [Abstract][Full Text] [Related]
9. Hodgkin lymphoma post-transplant lymphoproliferative disorder following pediatric renal transplant: serial imaging with F-18 FDG PET/CT.
Makis W; Lisbona R; Derbekyan V
Clin Nucl Med; 2010 Sep; 35(9):704-5. PubMed ID: 20706047
[TBL] [Abstract][Full Text] [Related]
10. Positron emission tomography scanning in the setting of post-transplant lymphoproliferative disorders.
Blaes AH; Cioc AM; Froelich JW; Peterson BA; Dunitz JM
Clin Transplant; 2009; 23(6):794-9. PubMed ID: 20447185
[TBL] [Abstract][Full Text] [Related]
11. FDG PET imaging in the evaluation of post-transplant lymphoproliferative disorder following renal transplantation.
O'Conner AR; Franc BL
Nucl Med Commun; 2005 Dec; 26(12):1107-11. PubMed ID: 16264358
[TBL] [Abstract][Full Text] [Related]
12. The role of 18F-FDG PET/CT in the evaluation of pediatric transplant patients.
Yang J; Zhuang H
Hell J Nucl Med; 2015; 18(2):136-9. PubMed ID: 26187213
[TBL] [Abstract][Full Text] [Related]
13. Posttransplant Lymphoproliferative Disorder of the Thorax: CT and FDG-PET Features in a Single Tertiary Referral Center.
Yoon GY; Kim MY; Huh JR; Jo KW; Shim TS
Medicine (Baltimore); 2015 Aug; 94(31):e1274. PubMed ID: 26252295
[TBL] [Abstract][Full Text] [Related]
14. The value of
Si Z; Lu D; Zhai L; Zheng W; Dong C; Sun C; Wang K; Zhang W; Wei X; Zhang Z; Zhao S; Gao W; Shen Z
Pediatr Transplant; 2023 Aug; 27(5):e14501. PubMed ID: 36906739
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of F-18 FDG PET/CT in the evaluation of neck swelling in polymorphic posttransplant lymphoproliferative disorder after renal transplantation.
Kim SH; Zeon SK; Choi BW; Kim HW; Won KS; Kim SJ
Clin Nucl Med; 2011 Jul; 36(7):587-9. PubMed ID: 21637068
[TBL] [Abstract][Full Text] [Related]
16. Preliminary experience on the use of PET/CT in the management of pediatric post-transplant lymphoproliferative disorder.
Guerra-García P; Hirsch S; Levine DS; Taj MM
Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28612477
[TBL] [Abstract][Full Text] [Related]
17. (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in diagnosis of post-transplant lymphoproliferative disorder.
Panagiotidis E; Quigley AM; Pencharz D; Ardeshna K; Syed R; Sajjan R; Bomanji J
Leuk Lymphoma; 2014 Mar; 55(3):515-9. PubMed ID: 23772644
[TBL] [Abstract][Full Text] [Related]
18. FDG PET/CT Findings of Polymorphic Posttransplant Lymphoproliferative Disorders in a Transplanted Kidney.
Yang Y; Wang W; Kan Y; Liu J; Yang J
Clin Nucl Med; 2018 Jun; 43(6):441-444. PubMed ID: 29485445
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic performance of FDG-PET/CT of post-transplant lymphoproliferative disorder and factors affecting diagnostic yield.
Montes de Jesus FM; Kwee TC; Kahle XU; Nijland M; van Meerten T; Huls G; Dierckx RAJO; Rosati S; Diepstra A; van der Bij W; Verschuuren EAM; Glaudemans AWJM; Noordzij W
Eur J Nucl Med Mol Imaging; 2020 Mar; 47(3):529-536. PubMed ID: 31444510
[TBL] [Abstract][Full Text] [Related]
20. 18F-FDG PET for Detection of Primary Tracheobronchial T-/Natural Killer-Cell-Derived Posttransplant Lymphoproliferative Disorder After Lung Transplantation.
Derlin T; Braubach P; Kreipe HH; Hueper K
Clin Nucl Med; 2017 Dec; 42(12):988-989. PubMed ID: 29076909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
